These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 26174839)
1. Should procalcitonin be measured routinely in acute decompensated heart failure? Loncar G; Tscholl V; Tahirovic E; Sekularac N; Marx A; Obradovic D; Veskovic J; Lainscak M; von Haehling S; Edelmann F; Arandjelovic A; Apostolovic S; Stanojevic D; Pieske B; Trippel T; Dungen HD Biomark Med; 2015; 9(7):651-9. PubMed ID: 26174839 [TBL] [Abstract][Full Text] [Related]
2. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure. Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995 [TBL] [Abstract][Full Text] [Related]
3. Procalcitonin and long-term prognosis after an admission for acute heart failure. Villanueva MP; Mollar A; Palau P; Carratalá A; Núñez E; Santas E; Bodí V; Chorro FJ; Miñana G; Blasco ML; Sanchis J; Núñez J Eur J Intern Med; 2015 Jan; 26(1):42-8. PubMed ID: 25592074 [TBL] [Abstract][Full Text] [Related]
4. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure. Naffaa M; Makhoul BF; Tobia A; Jarous M; Kaplan M; Aronson D; Saliba W; Azzam ZS Am J Emerg Med; 2014 Jan; 32(1):44-9. PubMed ID: 24210886 [TBL] [Abstract][Full Text] [Related]
5. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score. Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162 [TBL] [Abstract][Full Text] [Related]
7. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure. Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712 [TBL] [Abstract][Full Text] [Related]
8. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment. Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495 [TBL] [Abstract][Full Text] [Related]
9. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis. Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study. Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696 [TBL] [Abstract][Full Text] [Related]
11. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels? Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618 [TBL] [Abstract][Full Text] [Related]
12. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial. Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M; Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870 [TBL] [Abstract][Full Text] [Related]
13. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial. Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907 [TBL] [Abstract][Full Text] [Related]
14. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T; Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641 [TBL] [Abstract][Full Text] [Related]
15. [Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure]. Wei BQ; Yang YJ; Zhang J; Dou KF; Zhang YH; Huang XH; Kang LM; Zhang CL; Gu Q; Gao X; Yang YM; Dai Y; Yu LT; Zhang HM; Lü R Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):481-5. PubMed ID: 19927625 [TBL] [Abstract][Full Text] [Related]
16. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels. Carrasco-Sánchez FJ; Pérez-Calvo JI; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio I; Barón-Franco B; Aguayo-Canela M; Pujol-De la llave E J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):115-21. PubMed ID: 24522084 [TBL] [Abstract][Full Text] [Related]
17. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Phua J; Koay ES; Lee KH Shock; 2008 Mar; 29(3):328-33. PubMed ID: 18277855 [TBL] [Abstract][Full Text] [Related]
18. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure. De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL; Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804 [TBL] [Abstract][Full Text] [Related]
19. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure. Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599 [TBL] [Abstract][Full Text] [Related]
20. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]